Page 2 - Mark Schoenfisch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vast Therapeutics Presents Promising Preclinical Results for Novel Treatment for NTM Disease

/PRNewswire/ Vast Therapeutics announces promising results with a nitric oxide releasing drug candidate under investigation for infections caused by.

John oakleyMark schoenfischTherapeutics incUniversity of south carolinaWorld bronchiectasisMark schoenfisch phdChief scientific officerPatrick flumeMedical universityAvast therapeuticsCystic fibrosisFinancial officer vast therapeutics

Vast Therapeutics Presents Promising Preclinical Results for Novel Treatment for NTM Disease

Vast Therapeutics Presents Promising Preclinical Results for Novel Treatment for NTM Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mark schoenfischTherapeutics incUniversity of south carolinaWorld bronchiectasisMark schoenfisch phdChief scientific officerPatrick flumeMedical universityAvast therapeuticsCystic fibrosis

-$0 55 Earnings Per Share Expected for Novan, Inc (NASDAQ:NOVN) This Quarter

Wall Street brokerages forecast that Novan, Inc. (NASDAQ:NOVN – Get Rating) will post ($0.55) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Novan’s earnings. The lowest EPS estimate is ($0.73) and the highest is ($0.46). Novan reported earnings per share of ($0.60) in the […]

Nathan staskoMark schoenfischVirtu financialZacks investment researchDe shaw coNovan incB riley wealth management incMillennium managementOak harbor wealth partnersWall streetGet ratingHarbor wealth partnersWealth managementRiley wealth managementNasdaq novn

Novan (NASDAQ:NOVN) Given Buy Rating at HC Wainwright

Novan (NASDAQ:NOVN – Get Rating)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a note issued to investors on Tuesday, TipRanks reports. They currently have a $24.00 target price on the stock. NOVN traded up $0.08 during trading on Tuesday, reaching $3.33. 500 shares of the company’s stock were exchanged, […]

Mark schoenfischNathan staskoNovan incMarshall waceVirtu financialRenaissance technologiesCapital partnersGet ratingNasdaq novnReiterated ratingHc wainwright

Triangle unemployment rate ticks upward but thousands of jobs remain available

Triangle unemployment rate ticks upward but thousands of jobs remain available
wraltechwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wraltechwire.com Daily Mail and Mail on Sunday newspapers.

Durham countyNorth carolinaUnited statesNorth carolina state universityOrange countyResearch triangle parkChapel hillDuke universityWake countyTergus pharmaRaleigh publicinputMark schoenfischAnthony rotoliFidelity investmentsAmerican marketing associationNational job boards